Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. (CLRB) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 94 transactions totaling $6.7M, demonstrating a bullish sentiment with $4.2M in net insider flow. The most recent transaction on Dec 12, 2025 involved a sale of 198 shares valued at $733.
CLRB Insider Activity Summary
Who Is Buying CLRB Stock?
No significant insider buying has been recorded for CLRB in the recent period.
Who Is Selling CLRB Stock?
No significant insider selling has been recorded for CLRB in the recent period.
Is Cellectar Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CLRB is bullish with an Insider Alignment Score of 82/100 and a net flow of $4.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CLRB Frequently Asked Questions
Understanding CLRB Insider Activity
Insider trading at Cellectar Biosciences, Inc. (CLRB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading CLRB stock, having executed 94 transactions in the past 90 days. The most active insider is Richard Hertzberg (Executive), who has made 13 transactions totaling $2.4M.
Related Tools
Track Cellectar Biosciences, Inc. Insider Activity
Get notified when executives and directors at CLRB file new Form 4 transactions